CN111802550A - Probiotic formula beverage and preparation method thereof - Google Patents
Probiotic formula beverage and preparation method thereof Download PDFInfo
- Publication number
- CN111802550A CN111802550A CN202010739866.XA CN202010739866A CN111802550A CN 111802550 A CN111802550 A CN 111802550A CN 202010739866 A CN202010739866 A CN 202010739866A CN 111802550 A CN111802550 A CN 111802550A
- Authority
- CN
- China
- Prior art keywords
- parts
- lactobacillus
- fermentation
- bifidobacterium
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 54
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 54
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 44
- 235000013361 beverage Nutrition 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title description 10
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 72
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 44
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 36
- 239000001259 polydextrose Substances 0.000 claims abstract description 36
- 229940035035 polydextrose Drugs 0.000 claims abstract description 36
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 36
- 229920001202 Inulin Polymers 0.000 claims abstract description 32
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 32
- 229940029339 inulin Drugs 0.000 claims abstract description 32
- 229960003080 taurine Drugs 0.000 claims abstract description 22
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 20
- 241000186012 Bifidobacterium breve Species 0.000 claims abstract description 20
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 20
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims abstract description 20
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 20
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 20
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 20
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 20
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 20
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 20
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 20
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims abstract description 20
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 20
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 20
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims abstract description 19
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 18
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 9
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 9
- 239000011718 vitamin C Substances 0.000 claims abstract description 9
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 claims abstract 6
- 238000000855 fermentation Methods 0.000 claims description 86
- 230000004151 fermentation Effects 0.000 claims description 86
- 230000001954 sterilising effect Effects 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 18
- 238000010438 heat treatment Methods 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 13
- 229930003231 vitamin Natural products 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 8
- 238000011049 filling Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 7
- 238000007789 sealing Methods 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 claims description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 19
- 238000010521 absorption reaction Methods 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 18
- 235000013305 food Nutrition 0.000 abstract description 13
- 230000009286 beneficial effect Effects 0.000 abstract description 11
- 230000035622 drinking Effects 0.000 abstract description 11
- 230000035755 proliferation Effects 0.000 abstract description 9
- 241000186000 Bifidobacterium Species 0.000 abstract description 6
- 239000011575 calcium Substances 0.000 abstract description 6
- 208000008589 Obesity Diseases 0.000 abstract description 5
- 235000020824 obesity Nutrition 0.000 abstract description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 4
- 241000186660 Lactobacillus Species 0.000 abstract description 4
- 229910052791 calcium Inorganic materials 0.000 abstract description 4
- 229940039696 lactobacillus Drugs 0.000 abstract description 4
- 230000000968 intestinal effect Effects 0.000 abstract description 3
- 230000002496 gastric effect Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 22
- 241000894006 Bacteria Species 0.000 description 14
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 14
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 5
- 206010009944 Colon cancer Diseases 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 208000029742 colonic neoplasm Diseases 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 239000004380 Cholic acid Substances 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 2
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 229960002471 cholic acid Drugs 0.000 description 2
- 235000019416 cholic acid Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- -1 lipid compounds Chemical class 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000003471 mutagenic agent Substances 0.000 description 2
- 231100000707 mutagenic chemical Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 230000004693 neuron damage Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000000960 hypophysis hormone Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the technical field of food processing, in particular to a probiotic formula beverage, which comprises the following raw materials: stachyose, inulin, polydextrose, streptococcus thermophilus, bifidobacterium lactis, lactobacillus rhamnosus, lactobacillus bulgaricus, lactobacillus plantarum, bifidobacterium longum, bifidobacterium breve, lactobacillus reuteri, vitamin C and taurine. The probiotic formula beverage prepared by the invention obviously improves the proliferation of intestinal and gastric probiotics after drinking for one week, has the effect of losing weight after drinking, has low sugar content, is not easy to be absorbed by human bodies, has low calorific value, can not cause obesity, can be used as weight-losing food and low-calorie food, has small blood sugar increase and obviously increased calcium absorption after drinking, has extremely obvious proliferation effect on beneficial flora such as bifidobacterium, lactobacillus and the like in the gastrointestinal tract of human bodies, can quickly improve the internal environment of the digestive tract of human bodies, and can regulate the balance of microecological flora.
Description
Technical Field
The invention relates to the technical field of food processing, in particular to a probiotic formula beverage and a preparation method thereof.
Background
Probiotics refer to active microorganisms having an excellent influence on humans, animals, and the like. People can protect the intestinal tract of the human body by taking the probiotics, thereby maintaining the normal metabolism of the human body. With the acceleration of the life rhythm of people, people do not have time to cook, and three daily meals are solved through takeaway. But the little takeaway is the favorite food of people, thereby making people's dietary structure single, and then leading to that the diet law is disturbed, makes the probiotic in the stomach reduce, induces the emergence of stomach disease.
Disclosure of Invention
The invention aims to provide a probiotic formula beverage and a preparation method thereof, and aims to solve the problems that the current takeout causes the eating regularity of people to be disturbed, so that the probiotics in the stomach is reduced, and the stomach diseases are induced.
In order to achieve the purpose, the invention provides the following technical scheme:
the probiotic formula beverage comprises the following raw materials in parts by weight: stachyose: 30-40 parts of inulin: 15-20 parts of polydextrose: 20-30 parts of streptococcus thermophilus, 1-5 parts of bifidobacterium lactis, 2-4 parts of lactobacillus rhamnosus, 3-5 parts of lactobacillus bulgaricus, 3-5 parts of lactobacillus plantarum, 3-5 parts of bifidobacterium longum, 3-5 parts of bifidobacterium breve, 3-5 parts of lactobacillus reuteri, 3-5 parts of vitamin C1-5 parts and 0.5-1.5 parts of taurine.
Preferably, the feed comprises the following raw materials in parts by weight: stachyose: 30 parts of inulin: 18 parts of polydextrose: 25 parts of streptococcus thermophilus, 3 parts of bifidobacterium lactis, 4 parts of lactobacillus rhamnosus, 4 parts of lactobacillus bulgaricus, 4 parts of lactobacillus plantarum, 4 parts of bifidobacterium longum, 3 parts of bifidobacterium breve, 5 parts of lactobacillus reuteri, vitamin C2 and 1 part of taurine.
Preferably, the feed comprises the following raw materials in parts by weight: stachyose: 35 parts of inulin: 20 parts of polydextrose: 20 parts of streptococcus thermophilus, 5 parts of bifidobacterium lactis, 3 parts of lactobacillus rhamnosus, 4 parts of lactobacillus bulgaricus, 3.5 parts of lactobacillus plantarum, 4 parts of bifidobacterium longum, 4 parts of bifidobacterium breve, 3 parts of lactobacillus reuteri, vitamin C3 and 1.2 parts of taurine.
Preferably, the feed comprises the following raw materials in parts by weight: stachyose: 40 parts of inulin: 20 parts of polydextrose: 30 parts of streptococcus thermophilus, 2 parts of bifidobacterium lactis, 3 parts of lactobacillus rhamnosus, 3 parts of lactobacillus bulgaricus, 4 parts of lactobacillus plantarum, 4 parts of bifidobacterium longum, 5 parts of bifidobacterium breve, 5 parts of lactobacillus reuteri, vitamin C5 and 1.5 parts of taurine.
On the other hand, the invention also provides a probiotic formula beverage, which comprises the probiotic formula beverage, and specifically comprises the following steps:
s1: weighing the raw material components in parts by weight;
s2: sterilizing the fermentation container with ultraviolet rays and sterilizing at high temperature;
s3: adding the weighed stachyose, inulin, polydextrose, vitamin C, taurine and purified water into a fermentation container;
s4: heating the mixed liquid in the fermentation container while stirring, preserving heat at 35 ℃, and performing primary fermentation;
s5: after the first fermentation is finished, adding the weighed streptococcus thermophilus, bifidobacterium lactis, lactobacillus rhamnosus, lactobacillus bulgaricus, lactobacillus plantarum, bifidobacterium longum, bifidobacterium breve and lactobacillus reuteri into a fermentation container for second fermentation;
s6: after fermentation is finished, cooling the probiotic by a cold-heat exchanger, filling, sealing, spraying code on a bottle cap, inspecting, and attaching a mark to obtain the probiotic beverage.
Preferably, the specific steps in step S2 are: sterilizing the fermentation container in an ultraviolet sterilizing box for 5-10min, cleaning with clear water for 2-3 times, sterilizing at 95-100 deg.C for 10-15min, and cooling to 60-65 deg.C.
Preferably, the mixing and stirring time is 15-20min, and the heating temperature is 30-35 ℃.
Preferably, the time for the first fermentation is 3-5 h.
Preferably, when the second fermentation is carried out, the fermentation temperature in the fermentation container is 40-43 ℃, and the fermentation time is 10-12 h.
In the probiotic formula beverage prepared by the invention, the added stachyose has very obvious proliferation effect on beneficial flora such as bifidobacterium, lactobacillus and the like in the gastrointestinal tract of a human body, and can quickly improve the environment in the gastrointestinal tract of the human body and adjust the balance of microecological flora. It can promote the formation of dominant bacteria status of beneficial bacteria in digestive tract, inhibit the production of putrefying bacteria such as Clostridium acidogenum and the like, produce a large amount of physiological active substances, regulate the pH value of intestinal tract, kill pathogenic bacteria, inhibit the generation of putrefying products, inhibit the generation and absorption of endogenous carcinogens, and decompose and derive multiple immune function factors.
Inulin can control blood lipid, effectively reduce serum Total Cholesterol (TC) and low density lipoprotein cholesterol (LDL-C), increase high density lipoprotein/low density lipoprotein ratio, and improve blood lipid condition; inulin can lower blood sugar, and inulin is not hydrolyzed into monosaccharide at upper part of intestinal tract, so as not to raise blood sugar level and insulin content; inulin can also promote mineral absorption, and greatly increase Ca content2+、Mg2+、Zn2+、Cu2+、Fe2+Absorption of iso-minerals; inulin can regulate intestinal microbial flora, improve intestinal health, and prevent constipation; can effectively inhibit the generation of toxic fermentation products, protect the liver and prevent colon cancer; in addition, the inulin contains a small amount of 2-9 fructo-oligosaccharide, which can increase the expression of brain nerve cell trophic factor, has good protection effect on corticosterone-induced neuron damage, and has good antidepressant effect.
Polydextrose is a alias of water-soluble dietary fiber, is white or off-white solid particles, is easily soluble in water, has a solubility of 70%, has a pH value of 2.5-7.0 in a 10% aqueous solution, has no special flavor, and can regulate lipid metabolism: polydextrose can form a film in the small intestine and wrap part of food fat, so that the absorption of fat in the digestive tract can be effectively limited, the excretion of lipid compounds can be promoted, the satiety can be increased, and the food intake can be reduced, thereby achieving the effects of regulating blood fat, reducing fat accumulation, preventing obesity and the like; polydextrose can reduce cholesterol, adsorb organic molecules such as bile acid and cholesterol mutagen, inhibit Total Cholesterol (TC) concentration increase, reduce synthesis and absorption of cholic acid and salts, reduce cholesterol level in blood plasma and liver, prevent and treat coronary arteriosclerosis and cholelithiasis, and prevent cardiovascular and cerebrovascular diseases; polydextrose can reduce the sugar absorption, prevent food from fully contacting digestive juice, inhibit the secretion of hyperglycosemin, and promote the absorption of glucose to slow down, thereby reducing the postprandial blood sugar level, fully playing the role of insulin, and preventing diabetes; polydextrose can prevent and treat constipation: polydextrose can absorb water and swell in human intestinal tracts and keep water, so that the volume of excrement is increased, intestinal tract peristalsis is stimulated, defecation frequency is accelerated, and effects of relaxing bowel and preventing constipation are achieved; polydextrose can expel toxin and beautify the face: the polydextrose can effectively regulate the pH value of intestinal tract, improve the breeding environment of beneficial bacteria and quickly expand beneficial bacteria such as bifidobacterium and the like, thereby inhibiting the growth of saprophytic bacteria, preventing the atrophy of intestinal mucosa, timely excreting toxin and metabolic waste in vivo, avoiding the toxin from being discharged from the skin, achieving the effects of beautifying the skin and preventing diseases such as hemorrhoids, gastroenteritis, colon cancer and the like.
The vitamin C can improve immunity, prevent cancer, heart disease and apoplexy, protect teeth and gum, and reduce skin melanin pigmentation by keeping on time, thereby reducing black speck and freckle, whitening skin, promoting metabolism of tyrosine and tryptophan in amino acid, and prolonging life of human body.
The taurine has rich and widely distributed content in brain, can obviously promote the growth and development of nervous system and the proliferation and differentiation of cells, is dose-dependent, plays an important role in the development process of brain nerve cells, improves nerve conduction and visual function, can inhibit platelet aggregation in a circulatory system, reduces blood fat, maintains normal blood pressure of human body and prevents arteriosclerosis; has protective effect on myocardial cells, and can be used for treating arrhythmia; has special therapeutic effect on lowering blood cholesterol level, and can be used for treating heart failure, taurine has effects of promoting pituitary hormone secretion, activating pancreatic gland function, improving endocrine system state, regulating metabolism, enhancing immunity, and relieving fatigue.
Compared with the prior art, the invention has the beneficial effects that: the probiotics formula beverage and the probiotics formula beverage prepared by the preparation method thereof obviously improve the proliferation of the probiotics in the intestinal tract and the stomach after drinking for one week, have the effect of losing weight after drinking, have low sugar content, are not easy to be absorbed by human bodies, have very low heat value, can not cause obesity, can be used as weight-losing food and low-calorie food, have small blood sugar increase and obviously increased calcium absorption after drinking, have very obvious proliferation effect on beneficial flora such as bifidobacterium, lactobacillus and the like in the gastrointestinal tract of human bodies, can quickly improve the environment in the digestive tract of the human bodies, and adjust the balance of micro-ecological flora.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The probiotic formula beverage comprises the following raw materials in parts by weight: stachyose: 30 parts of inulin: 18 parts of polydextrose: 25 parts of streptococcus thermophilus, 3 parts of bifidobacterium lactis, 4 parts of lactobacillus rhamnosus, 4 parts of lactobacillus bulgaricus, 4 parts of lactobacillus plantarum, 4 parts of bifidobacterium longum, 3 parts of bifidobacterium breve, 5 parts of lactobacillus reuteri, vitamin C2 and 1 part of taurine.
The preparation method of the probiotic formula beverage in the embodiment specifically comprises the following steps:
s1: weighing the raw material components in parts by weight;
s2: sterilizing the fermentation container with ultraviolet rays and sterilizing at high temperature;
s3: adding the weighed stachyose, inulin, polydextrose, vitamin C, taurine and purified water into a fermentation container;
s4: heating the mixed liquid in the fermentation container while stirring, preserving heat at 35 ℃, and performing primary fermentation;
s5: after the first fermentation is finished, adding the weighed streptococcus thermophilus, bifidobacterium lactis, lactobacillus rhamnosus, lactobacillus bulgaricus, lactobacillus plantarum, bifidobacterium longum, bifidobacterium breve and lactobacillus reuteri into a fermentation container for second fermentation;
s6: after fermentation is finished, cooling the probiotic by a cold-heat exchanger, filling, sealing, spraying code on a bottle cap, inspecting, and attaching a mark to obtain the probiotic beverage.
Specifically, the specific steps in step S2 are: sterilizing the fermentation container in an ultraviolet sterilizing box for 6min, cleaning with clear water for 2 times, sterilizing at 100 deg.C for 12min, and cooling to 60 deg.C.
Further, the mixing and stirring time was 15min, and the heating temperature was 32 ℃.
It is worth noting that the time for the first fermentation was 4 hours.
In addition, in the second fermentation, the fermentation temperature in the fermentation vessel was 42 ℃ and the fermentation time was 10 hours.
Example 2
The probiotic formula beverage comprises the following components in percentage by weight: the feed comprises the following raw materials in parts by weight: stachyose: 35 parts of inulin: 20 parts of polydextrose: 20 parts of streptococcus thermophilus, 5 parts of bifidobacterium lactis, 3 parts of lactobacillus rhamnosus, 4 parts of lactobacillus bulgaricus, 3.5 parts of lactobacillus plantarum, 4 parts of bifidobacterium longum, 4 parts of bifidobacterium breve, 3 parts of lactobacillus reuteri, vitamin C3 and 1.2 parts of taurine.
The preparation method of the probiotic formula beverage in the embodiment specifically comprises the following steps:
s1: weighing the raw material components in parts by weight;
s2: sterilizing the fermentation container with ultraviolet rays and sterilizing at high temperature;
s3: adding the weighed stachyose, inulin, polydextrose, vitamin C, taurine and purified water into a fermentation container;
s4: heating the mixed liquid in the fermentation container while stirring, preserving heat at 35 ℃, and performing primary fermentation;
s5: after the first fermentation is finished, adding the weighed streptococcus thermophilus, bifidobacterium lactis, lactobacillus rhamnosus, lactobacillus bulgaricus, lactobacillus plantarum, bifidobacterium longum, bifidobacterium breve and lactobacillus reuteri into a fermentation container for second fermentation;
s6: after fermentation is finished, cooling the probiotic by a cold-heat exchanger, filling, sealing, spraying code on a bottle cap, inspecting, and attaching a mark to obtain the probiotic beverage.
Specifically, the specific steps in step S2 are: sterilizing the fermentation container in an ultraviolet sterilizing box for 6min, cleaning with clear water for 2 times, sterilizing at 100 deg.C for 12min, and cooling to 60 deg.C.
Further, the mixing and stirring time was 15min, and the heating temperature was 32 ℃.
It is worth noting that the time for the first fermentation was 4 hours.
In addition, in the second fermentation, the fermentation temperature in the fermentation vessel was 42 ℃ and the fermentation time was 10 hours.
Example 3
The probiotic formula beverage comprises the following raw materials in parts by weight: stachyose: 40 parts of inulin: 20 parts of polydextrose: 30 parts of streptococcus thermophilus, 2 parts of bifidobacterium lactis, 3 parts of lactobacillus rhamnosus, 3 parts of lactobacillus bulgaricus, 4 parts of lactobacillus plantarum, 4 parts of bifidobacterium longum, 5 parts of bifidobacterium breve, 5 parts of lactobacillus reuteri, vitamin C5 and 1.5 parts of taurine.
The preparation method of the probiotic formula beverage in the embodiment specifically comprises the following steps:
s1: weighing the raw material components in parts by weight;
s2: sterilizing the fermentation container with ultraviolet rays and sterilizing at high temperature;
s3: adding the weighed stachyose, inulin, polydextrose, vitamin C, taurine and purified water into a fermentation container;
s4: heating the mixed liquid in the fermentation container while stirring, preserving heat at 35 ℃, and performing primary fermentation;
s5: after the first fermentation is finished, adding the weighed streptococcus thermophilus, bifidobacterium lactis, lactobacillus rhamnosus, lactobacillus bulgaricus, lactobacillus plantarum, bifidobacterium longum, bifidobacterium breve and lactobacillus reuteri into a fermentation container for second fermentation;
s6: after fermentation is finished, cooling the probiotic by a cold-heat exchanger, filling, sealing, spraying code on a bottle cap, inspecting, and attaching a mark to obtain the probiotic beverage.
Specifically, the specific steps in step S2 are: sterilizing the fermentation container in an ultraviolet sterilizing box for 6min, cleaning with clear water for 2 times, sterilizing at 100 deg.C for 12min, and cooling to 60 deg.C.
Further, the mixing and stirring time was 15min, and the heating temperature was 32 ℃.
It is worth noting that the time for the first fermentation was 4 hours.
In addition, in the second fermentation, the fermentation temperature in the fermentation vessel was 42 ℃ and the fermentation time was 10 hours.
Comparative example 1
A probiotic formula beverage, inulin: 20 parts of polydextrose: 30 parts of streptococcus thermophilus, 3 parts of bifidobacterium lactis, 3 parts of lactobacillus rhamnosus, 3 parts of lactobacillus bulgaricus, 3 parts of lactobacillus plantarum, 3 parts of bifidobacterium longum, 3 parts of bifidobacterium breve, 3 parts of lactobacillus reuteri, vitamin C3 and 1 part of taurine.
The preparation method of the probiotic formula beverage in the embodiment specifically comprises the following steps:
s1: weighing the raw material components in parts by weight;
s2: sterilizing the fermentation container with ultraviolet rays and sterilizing at high temperature;
s3: adding the weighed inulin, polydextrose, vitamin C, taurine and purified water into a fermentation container;
s4: heating the mixed liquid in the fermentation container while stirring, preserving heat at 35 ℃, and performing primary fermentation;
s5: after the first fermentation is finished, adding the weighed streptococcus thermophilus, bifidobacterium lactis, lactobacillus rhamnosus, lactobacillus bulgaricus, lactobacillus plantarum, bifidobacterium longum, bifidobacterium breve and lactobacillus reuteri into a fermentation container for second fermentation;
s6: after fermentation is finished, cooling the probiotic by a cold-heat exchanger, filling, sealing, spraying code on a bottle cap, inspecting, and attaching a mark to obtain the probiotic beverage.
Specifically, the specific steps in step S2 are: sterilizing the fermentation container in an ultraviolet sterilizing box for 6min, cleaning with clear water for 2 times, sterilizing at 100 deg.C for 12min, and cooling to 60 deg.C.
Further, the mixing and stirring time was 15min, and the heating temperature was 32 ℃.
It is worth noting that the time for the first fermentation was 4 hours.
In addition, in the second fermentation, the fermentation temperature in the fermentation vessel was 42 ℃ and the fermentation time was 10 hours.
Comparative example 2
The probiotic formula beverage comprises the following raw materials in parts by weight: stachyose: 50 parts of inulin: 30 parts of polydextrose: 30 parts of streptococcus thermophilus, 5 parts of bifidobacterium lactis, 4 parts of lactobacillus rhamnosus, 2 parts of lactobacillus bulgaricus, 1 part of lactobacillus plantarum, 3 parts of bifidobacterium longum, 5 parts of bifidobacterium breve, 5 parts of lactobacillus reuteri, vitamin C3 and 1.5 parts of taurine.
The preparation method of the probiotic formula beverage in the embodiment comprises the following steps:
s1 cleaning and disinfecting: sterilizing the stirrer at high temperature, cleaning with clear water for at least five times, drying the stirrer in a dryer, and preheating to 65 ℃;
s2 mixing and stirring raw materials: weighing collagen, fruit powder, mangosteen powder, pomegranate powder, rose pollen and momordica grosvenori sweet according to the weight percentage, adding purified water, and putting into a stirrer;
s3 heating and stirring: heating the feed liquid in the stirrer while stirring, preserving heat at 40 ℃, and stirring;
s4 packaging: and after stirring, cooling by a cold-heat exchanger, filling, sealing, spraying codes on a bottle cap, inspecting, and attaching a mark to obtain the collagen beverage.
In the embodiment, the sterilization temperature is 95-100 ℃, the sterilization time is 10-15min, the stirring speed of the stirrer is 400-.
Comparing the sugar content, the proliferation promoting amount of the probiotics in the intestinal tract and the stomach after drinking for one week, the weight-reducing effect after one week, the instantaneous increment of blood sugar after drinking and the calcium absorption effect of the probiotic formula beverage prepared by the group of 3 examples and the group of 2 in proportion, the following table shows that:
the probiotics formula beverage prepared by the invention obviously improves the proliferation of the probiotics in the intestinal tract and the stomach after drinking for one week, has the effect of losing weight after drinking, has low sugar content, is not easy to be absorbed by human bodies, has very low heat value, can not cause obesity, can be used as weight-losing food and low-calorie food, has small blood sugar improving amount and obviously increased calcium absorption after drinking, has extremely obvious proliferation effect on beneficial bacteria groups such as bifidobacterium, lactobacillus and the like in the gastrointestinal tract of human bodies, can quickly improve the internal environment of the digestive tract of the human bodies, and can regulate the balance of micro-ecological bacteria groups. It can promote the formation of dominant bacteria status of beneficial bacteria in digestive tract, inhibit the production of putrefying bacteria such as Clostridium acidogenum and the like, produce a large amount of physiological active substances, regulate the pH value of intestinal tract, kill pathogenic bacteria, inhibit the generation of putrefying products, inhibit the generation and absorption of endogenous carcinogens, and decompose and derive multiple immune function factors.
Inulin has effects of controlling blood lipid, effectively reducing serum Total Cholesterol (TC) and low density lipoprotein cholesterol (LDL-C), and extractingHigh density lipoprotein/low density lipoprotein ratio, improving blood lipid condition; inulin can lower blood sugar, and inulin is not hydrolyzed into monosaccharide at upper part of intestinal tract, so as not to raise blood sugar level and insulin content; inulin can also promote mineral absorption, and greatly increase Ca content2+、Mg2+、Zn2+、Cu2+、Fe2+Absorption of iso-minerals; inulin can regulate intestinal microbial flora, improve intestinal health, and prevent constipation; can effectively inhibit the generation of toxic fermentation products, protect the liver and prevent colon cancer; in addition, the inulin contains a small amount of 2-9 fructo-oligosaccharide, which can increase the expression of brain nerve cell trophic factor, has good protection effect on corticosterone-induced neuron damage, and has good antidepressant effect.
Polydextrose is a alias of water-soluble dietary fiber, is white or off-white solid particles, is easily soluble in water, has a solubility of 70%, has a pH value of 2.5-7.0 in a 10% aqueous solution, has no special flavor, and can regulate lipid metabolism: polydextrose can form a film in the small intestine and wrap part of food fat, so that the absorption of fat in the digestive tract can be effectively limited, the excretion of lipid compounds can be promoted, the satiety can be increased, and the food intake can be reduced, thereby achieving the effects of regulating blood fat, reducing fat accumulation, preventing obesity and the like; polydextrose can reduce cholesterol, adsorb organic molecules such as bile acid and cholesterol mutagen, inhibit Total Cholesterol (TC) concentration increase, reduce synthesis and absorption of cholic acid and salts, reduce cholesterol level in blood plasma and liver, prevent and treat coronary arteriosclerosis and cholelithiasis, and prevent cardiovascular and cerebrovascular diseases; polydextrose can reduce the sugar absorption, prevent food from fully contacting digestive juice, inhibit the secretion of hyperglycosemin, and promote the absorption of glucose to slow down, thereby reducing the postprandial blood sugar level, fully playing the role of insulin, and preventing diabetes; polydextrose can prevent and treat constipation: polydextrose can absorb water and swell in human intestinal tracts and keep water, so that the volume of excrement is increased, intestinal tract peristalsis is stimulated, defecation frequency is accelerated, and effects of relaxing bowel and preventing constipation are achieved; polydextrose can expel toxin and beautify the face: the polydextrose can effectively regulate the pH value of intestinal tract, improve the breeding environment of beneficial bacteria and quickly expand beneficial bacteria such as bifidobacterium and the like, thereby inhibiting the growth of saprophytic bacteria, preventing the atrophy of intestinal mucosa, timely excreting toxin and metabolic waste in vivo, avoiding the toxin from being discharged from the skin, achieving the effects of beautifying the skin and preventing diseases such as hemorrhoids, gastroenteritis, colon cancer and the like.
The vitamin C can improve immunity, prevent cancer, heart disease and apoplexy, protect teeth and gum, and reduce skin melanin pigmentation by keeping on time, thereby reducing black speck and freckle, whitening skin, promoting metabolism of tyrosine and tryptophan in amino acid, and prolonging life of human body.
The foregoing shows and describes the general principles, essential features, and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, and the preferred embodiments of the present invention are described in the above embodiments and the description, and are not intended to limit the present invention. The scope of the invention is defined by the appended claims and equivalents thereof.
Claims (9)
1. A probiotic formula beverage, which is characterized in that: the feed comprises the following raw materials in parts by weight: stachyose: 30-40 parts of inulin: 15-20 parts of polydextrose: 20-30 parts of streptococcus thermophilus, 1-5 parts of bifidobacterium lactis, 2-4 parts of lactobacillus rhamnosus, 3-5 parts of lactobacillus bulgaricus, 3-5 parts of lactobacillus plantarum, 3-5 parts of bifidobacterium longum, 3-5 parts of bifidobacterium breve, 3-5 parts of lactobacillus reuteri, 3-5 parts of vitamin C1-5 parts and 0.5-1.5 parts of taurine.
2. The probiotic formula beverage according to claim 1, characterized in that: the feed comprises the following raw materials in parts by weight: stachyose: 30 parts of inulin: 18 parts of polydextrose: 25 parts of streptococcus thermophilus, 3 parts of bifidobacterium lactis, 4 parts of lactobacillus rhamnosus, 4 parts of lactobacillus bulgaricus, 4 parts of lactobacillus plantarum, 4 parts of bifidobacterium longum, 3 parts of bifidobacterium breve, 5 parts of lactobacillus reuteri, vitamin C2 and 1 part of taurine.
3. The probiotic formula beverage according to claim 1, characterized in that: the feed comprises the following raw materials in parts by weight: stachyose: 35 parts of inulin: 20 parts of polydextrose: 20 parts of streptococcus thermophilus, 5 parts of bifidobacterium lactis, 3 parts of lactobacillus rhamnosus, 4 parts of lactobacillus bulgaricus, 3.5 parts of lactobacillus plantarum, 4 parts of bifidobacterium longum, 4 parts of bifidobacterium breve, 3 parts of lactobacillus reuteri, vitamin C3 and 1.2 parts of taurine.
4. The probiotic formula beverage according to claim 1, characterized in that: the feed comprises the following raw materials in parts by weight: stachyose: 40 parts of inulin: 20 parts of polydextrose: 30 parts of streptococcus thermophilus, 2 parts of bifidobacterium lactis, 3 parts of lactobacillus rhamnosus, 3 parts of lactobacillus bulgaricus, 4 parts of lactobacillus plantarum, 4 parts of bifidobacterium longum, 5 parts of bifidobacterium breve, 5 parts of lactobacillus reuteri, vitamin C5 and 1.5 parts of taurine.
5. A method for preparing a probiotic formula beverage, comprising the probiotic formula beverage according to any one of claims 1 to 4, characterized in that: the method specifically comprises the following steps:
s1: weighing the raw material components in parts by weight;
s2: sterilizing the fermentation container with ultraviolet rays and sterilizing at high temperature;
s3: adding the weighed stachyose, inulin, polydextrose, vitamin C, taurine and purified water into a fermentation container;
s4: heating the mixed liquid in the fermentation container while stirring, preserving heat at 35 ℃, and performing primary fermentation;
s5: after the first fermentation is finished, adding the weighed streptococcus thermophilus, bifidobacterium lactis, lactobacillus rhamnosus, lactobacillus bulgaricus, lactobacillus plantarum, bifidobacterium longum, bifidobacterium breve and lactobacillus reuteri into a fermentation container for second fermentation;
s6: after fermentation is finished, cooling the probiotic by a cold-heat exchanger, filling, sealing, spraying code on a bottle cap, inspecting, and attaching a mark to obtain the probiotic beverage.
6. The method of preparing a probiotic formula beverage according to claim 5, characterized in that: the specific steps in step S2 are: sterilizing the fermentation container in an ultraviolet sterilizing box for 5-10min, cleaning with clear water for 2-3 times, sterilizing at 95-100 deg.C for 10-15min, and cooling to 60-65 deg.C.
7. The method of preparing a probiotic formula beverage according to claim 5, characterized in that: mixing and stirring for 15-20min, and heating at 30-35 deg.C.
8. The method of preparing a probiotic formula beverage according to claim 5, characterized in that: the time of the first fermentation is 3-5 h.
9. The method of preparing a probiotic formula beverage according to claim 5, characterized in that: when the second fermentation is carried out, the fermentation temperature in the fermentation container is 40-43 ℃, and the fermentation time is 10-12 h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010739866.XA CN111802550A (en) | 2020-07-28 | 2020-07-28 | Probiotic formula beverage and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010739866.XA CN111802550A (en) | 2020-07-28 | 2020-07-28 | Probiotic formula beverage and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111802550A true CN111802550A (en) | 2020-10-23 |
Family
ID=72862920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010739866.XA Pending CN111802550A (en) | 2020-07-28 | 2020-07-28 | Probiotic formula beverage and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111802550A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112438358A (en) * | 2020-11-17 | 2021-03-05 | 上海昊岳食品科技有限公司 | Liver-protecting probiotic solid beverage and preparation method thereof |
CN112717083A (en) * | 2021-03-05 | 2021-04-30 | 郭宝叶 | A Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method |
CN114259058A (en) * | 2021-12-29 | 2022-04-01 | 杭州壹旬科技有限公司 | Metazoan with slow carbon and fat reduction functions |
WO2023237684A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
WO2023237689A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
WO2023237686A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
WO2023237688A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
-
2020
- 2020-07-28 CN CN202010739866.XA patent/CN111802550A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112438358A (en) * | 2020-11-17 | 2021-03-05 | 上海昊岳食品科技有限公司 | Liver-protecting probiotic solid beverage and preparation method thereof |
CN112717083A (en) * | 2021-03-05 | 2021-04-30 | 郭宝叶 | A Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method |
CN114259058A (en) * | 2021-12-29 | 2022-04-01 | 杭州壹旬科技有限公司 | Metazoan with slow carbon and fat reduction functions |
WO2023237684A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
WO2023237689A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
WO2023237686A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
WO2023237688A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111802550A (en) | Probiotic formula beverage and preparation method thereof | |
CN109430666A (en) | A kind of Freeze-dry Powder of Probioctics solid beverage | |
WO2022016774A1 (en) | Composition beneficial for regulating intestinal tract, promoting digestion and improving constipation, and preparation method therefor | |
CN108812909B (en) | Complementary food nutritional supplement for improving monophagia or anorexia and preparation method thereof | |
CN100542430C (en) | A kind of nutrition albumen powder that contains profitable probliotics | |
CN110338402A (en) | A kind of compound probiotic powder and preparation method thereof | |
CN109846035A (en) | A kind of compound probiotic composition with body weight control | |
CN111387388A (en) | Probiotic beverage assisting in regulating gastric flora and preparation method thereof | |
CN111387387A (en) | Probiotic beverage for assisting in adjusting intestinal flora and preparation method thereof | |
CN112617083A (en) | Prebiotics solid beverage capable of relaxing bowel and reducing blood sugar and preparation method thereof | |
KR20040027180A (en) | Lactic Acid Bacteria-Fermenting Dairy Products Used for Preventing and Treating Obesity or Diabetes Mellitus and Manufacturing Method thereof | |
CN113974043A (en) | Prebiotics solid beverage and preparation method thereof | |
CN112704237A (en) | Vegetable peptide fat-reducing composition and eating method thereof | |
CN112931743A (en) | Solid beverage beneficial to body shaping and preparation method thereof | |
CN112385843A (en) | Balanced nutrition powder containing composite prebiotics and preparation method thereof | |
WO2024149132A1 (en) | Probiotic protein multivitamin and preparation method therefor | |
CN107319550A (en) | Brain trauma full nutrition formula food | |
CN110279048A (en) | A kind of composite fruit juice function factor beverage and preparation method thereof | |
CN102300472A (en) | Symbiotic composition, and method for manufacturing same | |
CN105707378A (en) | Black-highland barley coffee with effect of slimming | |
KR20040037011A (en) | Food Composition Containing a Lactic Acid Bacteria | |
CN115590069A (en) | Composition containing pea peptide and preparation method and application thereof | |
CN109303115A (en) | Raw ketone weight losing meal-replacing milk shake | |
CN114009508A (en) | Nutritional combined milk powder for coordinating gastrointestinal health and improving obesity and preparation method thereof | |
CN110959797A (en) | Prebiotics soybean protein peptide solid beverage and preparation process thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201023 |